The Pharmaceutical Needs Assessment (PNA) is a crucial part of the market entry system, and supports commissioning decisions based on patient needs, it is important that Health and Wellbeing Boards (HWBs) prepare PNAs to national comparable standards. The HWB has a duty to produce a Pharmaceutical Needs Assessment every three years. PNAs include:
- A statement of the pharmaceutical services provided that are necessary to meet needs in the area
- A statement of the pharmaceutical services that have been identified by the HWB that are needed in the area, and are not provided (gaps in provision)
- A statement of the other services which are provided, which are not needed, but which have secured improvements or better access to pharmaceutical services in the area
- A statement of the services that the HWB has identified as not being provided, but which would, if they were to be provided, secure improvements or better access to pharmaceutical services in the area
- A statement of other NHS services provided by a local authority, the NHS Commissioning Board (NHS England), an NHS Integrated Care Board (ICB) or an NHS Trust, which affect the needs for pharmaceutical services
- An explanation of how the assessment has been carried out (including how the consultation was carried out)
- A map of providers of pharmaceutical services
In March 2021, the Department of Health and Social Care (DHSC) announced that due to ongoing Covid-19 pressures across all sectors, the requirement to publish renewed PNAs would be suspended until October 2022 (see: Pharmaceutical Services Negotiating Committee - Latest news). DHSC's announcement means that renewed PNAs will not need to be published until April 2025 but Health and Wellbeing Boards will retain the ability to issue supplementary statements to respond to local changes and pharmaceutical needs during this time.
More information
Bury Pharmaceutical Needs Assessment 2022 - 2025 (Version 2.0)
A Pharmaceutical Needs Assessment (PNA) is a comprehensive assessment of whether current and future pharmaceutical services meet the needs of the local population.
Appendix 1 - Glossary
An alphabetical list of abbreviations relating to Pharmaceuticals, with explanations as to their meaning.
Appendix 2 - PNA Steering Group: Terms of Reference
Terms of reference for the Pharmaceutical Needs Assessment (PNA) Steering Group.
Appendix 3 - Public Survey Results - Bury
Survey ran 7th March 2022 to 15th May 2022 There were 159 responses.
Appendix 4 - Pharmacy Survey Results
Survey ran 19th January 2022 to 15th May 2022 There were 13 responses.
(This PDF is not fully accessible and may not be suitable for users of assistive technology. See: Accessible documents).
Appendix 5 - Commissioned Services
A list of enhanced and locally commissioned services through the borough of Bury.
Appendix 6 - Bury Pharmacies
List of Bury pharmacies and supporting information including neignbourhood, ward, map index, name, address, and contractor type.
Appendix 7 - Advanced Services
List of advanced services available in pharmacies throughout the borough of Bury.
Appendix 8 - Community Pharmacy Opening Hours
Pharmacy operating hours within each neighbourhood and ward.
Appendix 9 - PNA 60 Day Consultation Plan
The Pharmaceutical Needs Assessment (PNA) 60 Day Consultation Plan.
Appendix 11 - GP Practices
List of GP Practices within the borough of Bury including neighbourhood, ward, and addresses.
Appendix 12 - One Mile Boundary Pharmacies
Names, addresses, and area of pharmacies within one mile of Bury's boundary.
Appendix 13 - Analysis of PNA Consultation
Analysis of responses to the questions from the formal consultation period of the Pharmaceutical Needs Assessment.
(This PDF is not fully accessible and may not be suitable for users of assistive technology. See: Accessible documents).